Cargando…

Assessing the Prognostic Capability of Immune-Related Gene Scoring Systems in Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the commonest of the subtypes of lung cancer histologically. For this study, we intended to analyze the expression profiling of the immune-related genes (IRGs) from an independently available public database and developed a potent signature predictive of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenhao, Dong, Ruihong, Gao, Shuai, Shan, Xiaodi, Li, Mian, Yu, Zhaoyan, Sun, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357717/ https://www.ncbi.nlm.nih.gov/pubmed/35957802 http://dx.doi.org/10.1155/2022/2151396

Ejemplares similares

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
por: Ouyang, Wenhao, et al.
Publicado: (2022)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
por: Zhou, Chang-shuai, et al.
Publicado: (2021)

Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
por: Zuo, Shuguang, et al.
Publicado: (2020)

Identification of prognostic genes in lung adenocarcinoma immune microenvironment
por: Han, Lian-Kui, et al.
Publicado: (2021)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

A novel ferroptosis-related gene signature for prognostic prediction of patients with lung adenocarcinoma
por: Jin, Jingjing, et al.
Publicado: (2021)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2022)

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Prognostic impact of an integrative analysis of [(18)F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma
por: Choi, Jinyeong, et al.
Publicado: (2022)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma
por: Yuan, Lu, et al.
Publicado: (2021)

Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma
por: Peng, Xinyi, et al.
Publicado: (2023)

Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma
por: Shen, Yan, et al.
Publicado: (2022)

Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma
por: Zhu, Guangsheng, et al.
Publicado: (2021)

An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma
por: Xu, Zhiyun, et al.
Publicado: (2022)

The expression of POSTN and immune cell infiltration are prognostic factors of lung adenocarcinoma
por: Gao, Fang, et al.
Publicado: (2022)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
por: Xie, Hui, et al.
Publicado: (2021)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Genome-Wide Analysis of Lung Adenocarcinoma Identifies Novel Prognostic Factors and a Prognostic Score
por: Chen, Donglai, et al.
Publicado: (2019)

GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
por: Song, Shimao, et al.
Publicado: (2022)

Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2021)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma
por: Chen, Yusheng, et al.
Publicado: (2023)

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
por: Park, Hyung Soon, et al.
Publicado: (2016)

Postoperative survival According to the Glasgow Prognostic Score in Patients with Resected Lung Adenocarcinoma
por: Machida, Yuichiro, et al.
Publicado: (2016)

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Clustering analysis and prognostic signature of lung adenocarcinoma based on the tumor microenvironment
por: Shan, Qingqing, et al.
Publicado: (2022)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
por: Guo, Dina, et al.
Publicado: (2020)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lhqjg45o0j7dic23bmedqietol